Reduced cleavage of von willebrand factor by ADAMTS13 is associated with microangiopathic acute kidney injury following trauma. 2022

William E Plautz, and Shannon H Haldeman, and Mitchell R Dyer, and Jason L Sperry, and Francis X Guyette, and Patricia A Loughran, and Jurgis Alvikas, and Adnan Hassoune, and Lara Hoteit, and Nijmeh Alsaadi, and Brian S Zuckerbraun, and Marian A Rollins-Raval, and Jay S Raval, and Roberto I Mota, and Matthew D Neal, and
University of Pittsburgh School of Medicine.

Acute kidney injury (AKI) is common after trauma, but contributory factors are incompletely understood. Increases in plasma von Willebrand Factor (vWF) with concurrent decreases in ADAMTS13 are associated with renal microvascular thrombosis in other disease states, but similar findings have not been shown in trauma. We hypothesized that molecular changes in circulating vWF and ADAMTS13 promote AKI following traumatic injury. VWF antigen, vWF multimer composition and ADAMTS13 levels were compared in plasma samples from 16 trauma patients with and without trauma-induced AKI, obtained from the Prehospital Air Medical Plasma (PAMPer) biorepository. Renal histopathology and function, vWF and ADAMTS13 levels were assessed in parallel in a murine model of polytrauma and haemorrhage. VWF antigen was higher in trauma patients when compared with healthy controls [314% (253-349) vs. 100% (87-117)] [median (IQR)], while ADAMTS13 activity was lower [36.0% (30.1-44.7) vs. 100.0% (83.1-121.0)]. Patients who developed AKI showed significantly higher levels of high molecular weight multimeric vWF at 72-h when compared with non-AKI counterparts [32.9% (30.4-35.3) vs. 27.8% (24.6-30.8)]. Murine plasma cystatin C and vWF were elevated postpolytrauma model in mice, with associated decreases in ADAMTS13, and immunohistologic analysis demonstrated renal injury with small vessel plugs positive for fibrinogen and vWF. Following traumatic injury, the vWF-ADAMTS13 axis shifted towards a prothrombotic state in both trauma patients and a murine model. We further demonstrated that vWF-containing, microangiopathic deposits were concurrently produced as the prothrombotic changes were sustained during the days following trauma, potentially contributing to AKI development.

UI MeSH Term Description Entries
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008970 Molecular Weight The sum of the weight of all the atoms in a molecule. Molecular Weights,Weight, Molecular,Weights, Molecular
D010949 Plasma The residual portion of BLOOD that is left after removal of BLOOD CELLS by CENTRIFUGATION without prior BLOOD COAGULATION. Blood Plasma,Fresh Frozen Plasma,Blood Plasmas,Fresh Frozen Plasmas,Frozen Plasma, Fresh,Frozen Plasmas, Fresh,Plasma, Blood,Plasma, Fresh Frozen,Plasmas,Plasmas, Blood,Plasmas, Fresh Frozen
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000071120 ADAMTS13 Protein An ADAMTS protease that contains eight thrombospondin (TS) motifs. It cleaves VON WILLEBRAND FACTOR to control vWF-mediated THROMBOSIS. Mutations in the ADAMTS13 gene have been identified in familial cases of PURPURA, THROMBOTIC THROMBOCYTOPENIC and defects in ADAMTS13 activity are associated with MYOCARDIAL INFARCTION; BRAIN ISCHEMIA; PRE-ECLAMPSIA; and MALARIA. A Disintegrin and Metalloproteinase with Thrombospondin Motifs 13 Protein,ADAMTS-13 Protein,ADAMTS13 Protease,vWF-Cleaving Protease,von Willebrand Factor-Cleaving Protease,ADAMTS 13 Protein,vWF Cleaving Protease,von Willebrand Factor Cleaving Protease
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014841 von Willebrand Factor A high-molecular-weight plasma protein, produced by endothelial cells and megakaryocytes, that is part of the factor VIII/von Willebrand factor complex. The von Willebrand factor has receptors for collagen, platelets, and ristocetin activity as well as the immunologically distinct antigenic determinants. It functions in adhesion of platelets to collagen and hemostatic plug formation. The prolonged bleeding time in VON WILLEBRAND DISEASES is due to the deficiency of this factor. Factor VIII-Related Antigen,Factor VIIIR-Ag,Factor VIIIR-RCo,Plasma Factor VIII Complex,Ristocetin Cofactor,Ristocetin-Willebrand Factor,von Willebrand Protein,Factor VIII Related Antigen,Factor VIIIR Ag,Factor VIIIR RCo,Ristocetin Willebrand Factor
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D058186 Acute Kidney Injury Abrupt reduction in kidney function. Acute kidney injury encompasses the entire spectrum of the syndrome including acute kidney failure; ACUTE KIDNEY TUBULAR NECROSIS; and other less severe conditions. Acute Kidney Failure,Acute Kidney Insufficiency,Acute Renal Failure,Acute Renal Injury,Acute Renal Insufficiency,Kidney Failure, Acute,Kidney Insufficiency, Acute,Renal Failure, Acute,Renal Insufficiency, Acute,Acute Kidney Failures,Acute Kidney Injuries,Acute Kidney Insufficiencies,Acute Renal Failures,Acute Renal Injuries,Acute Renal Insufficiencies,Kidney Failures, Acute,Kidney Injuries, Acute,Kidney Injury, Acute,Kidney Insufficiencies, Acute,Renal Failures, Acute,Renal Injuries, Acute,Renal Injury, Acute,Renal Insufficiencies, Acute

Related Publications

William E Plautz, and Shannon H Haldeman, and Mitchell R Dyer, and Jason L Sperry, and Francis X Guyette, and Patricia A Loughran, and Jurgis Alvikas, and Adnan Hassoune, and Lara Hoteit, and Nijmeh Alsaadi, and Brian S Zuckerbraun, and Marian A Rollins-Raval, and Jay S Raval, and Roberto I Mota, and Matthew D Neal, and
May 2008, Proceedings of the National Academy of Sciences of the United States of America,
William E Plautz, and Shannon H Haldeman, and Mitchell R Dyer, and Jason L Sperry, and Francis X Guyette, and Patricia A Loughran, and Jurgis Alvikas, and Adnan Hassoune, and Lara Hoteit, and Nijmeh Alsaadi, and Brian S Zuckerbraun, and Marian A Rollins-Raval, and Jay S Raval, and Roberto I Mota, and Matthew D Neal, and
June 2015, Journal of thrombosis and haemostasis : JTH,
William E Plautz, and Shannon H Haldeman, and Mitchell R Dyer, and Jason L Sperry, and Francis X Guyette, and Patricia A Loughran, and Jurgis Alvikas, and Adnan Hassoune, and Lara Hoteit, and Nijmeh Alsaadi, and Brian S Zuckerbraun, and Marian A Rollins-Raval, and Jay S Raval, and Roberto I Mota, and Matthew D Neal, and
November 2006, Journal of thrombosis and haemostasis : JTH,
William E Plautz, and Shannon H Haldeman, and Mitchell R Dyer, and Jason L Sperry, and Francis X Guyette, and Patricia A Loughran, and Jurgis Alvikas, and Adnan Hassoune, and Lara Hoteit, and Nijmeh Alsaadi, and Brian S Zuckerbraun, and Marian A Rollins-Raval, and Jay S Raval, and Roberto I Mota, and Matthew D Neal, and
November 2017, Nephrology (Carlton, Vic.),
William E Plautz, and Shannon H Haldeman, and Mitchell R Dyer, and Jason L Sperry, and Francis X Guyette, and Patricia A Loughran, and Jurgis Alvikas, and Adnan Hassoune, and Lara Hoteit, and Nijmeh Alsaadi, and Brian S Zuckerbraun, and Marian A Rollins-Raval, and Jay S Raval, and Roberto I Mota, and Matthew D Neal, and
June 2025, Hepatology research : the official journal of the Japan Society of Hepatology,
William E Plautz, and Shannon H Haldeman, and Mitchell R Dyer, and Jason L Sperry, and Francis X Guyette, and Patricia A Loughran, and Jurgis Alvikas, and Adnan Hassoune, and Lara Hoteit, and Nijmeh Alsaadi, and Brian S Zuckerbraun, and Marian A Rollins-Raval, and Jay S Raval, and Roberto I Mota, and Matthew D Neal, and
September 2012, The Journal of biological chemistry,
William E Plautz, and Shannon H Haldeman, and Mitchell R Dyer, and Jason L Sperry, and Francis X Guyette, and Patricia A Loughran, and Jurgis Alvikas, and Adnan Hassoune, and Lara Hoteit, and Nijmeh Alsaadi, and Brian S Zuckerbraun, and Marian A Rollins-Raval, and Jay S Raval, and Roberto I Mota, and Matthew D Neal, and
October 2017, Medical engineering & physics,
William E Plautz, and Shannon H Haldeman, and Mitchell R Dyer, and Jason L Sperry, and Francis X Guyette, and Patricia A Loughran, and Jurgis Alvikas, and Adnan Hassoune, and Lara Hoteit, and Nijmeh Alsaadi, and Brian S Zuckerbraun, and Marian A Rollins-Raval, and Jay S Raval, and Roberto I Mota, and Matthew D Neal, and
January 2010, Blood,
William E Plautz, and Shannon H Haldeman, and Mitchell R Dyer, and Jason L Sperry, and Francis X Guyette, and Patricia A Loughran, and Jurgis Alvikas, and Adnan Hassoune, and Lara Hoteit, and Nijmeh Alsaadi, and Brian S Zuckerbraun, and Marian A Rollins-Raval, and Jay S Raval, and Roberto I Mota, and Matthew D Neal, and
December 2014, Proceedings of the National Academy of Sciences of the United States of America,
William E Plautz, and Shannon H Haldeman, and Mitchell R Dyer, and Jason L Sperry, and Francis X Guyette, and Patricia A Loughran, and Jurgis Alvikas, and Adnan Hassoune, and Lara Hoteit, and Nijmeh Alsaadi, and Brian S Zuckerbraun, and Marian A Rollins-Raval, and Jay S Raval, and Roberto I Mota, and Matthew D Neal, and
January 2020, Blood advances,
Copied contents to your clipboard!